International Recognition
MAI Motion —
Top 10 Finalist.
Independent international recognition of MAI Motion’s clinical relevance, commercial viability and global scalability — placing us among a select group of competitive digital health ventures.
Top 10
Global Finalist
2025
Award Year
1.71B
Global MSK Burden
About Santander X
A global platform for high-growth ventures.
Santander X supports high-growth ventures through international competition, mentorship, investor exposure and strategic networking — surfacing companies positioned for global scale.
Selection Criteria
“Reaching the Top 10 places MAI Motion among a select group of internationally competitive digital health companies.”
What Was Recognised
An AI-powered platform that
leaves the lab behind.
Markerless 3D Motion Capture
No markers, no sensors, no lab — just a standard mobile or laptop camera.
Real-Time Analysis
Computer vision and machine learning generate biomechanical analysis instantly.
Remote, Web-Based Deployment
Advanced musculoskeletal analytics accessible far beyond laboratory settings.
Personalised Biomarkers
Repeat longitudinal tracking with individual biomechanical signatures.
Why It Matters
Musculoskeletal disorders affect 1.71 billion people globally — yet early functional decline is frequently undetected. MAI Motion addresses that gap with earlier, objective, scalable assessment.
Recognised By
Acceleration, Not Endpoint
Global problems require
scalable solutions.
MAI Motion continues to expand clinical validation, strengthen AI development, refine remote deployment, and prepare for strategic investment. This recognition reinforces our trajectory toward delivering accessible, objective, AI-driven musculoskeletal care worldwide.